SOPHiA GENETICS S.A. Stock Analysis & AI Score
SOPHiA GENETICS S.A. (SOPH) has an ST Score of 41.5 (C), driven by its Momentum (A-) and held back by its Profitability (D-). Analysts rate it Buy with a $11.50 price target (+39.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
SOPHiA GENETICS S.A. (SOPH) has an ST Score of 41.5 (C), driven by its Momentum (A-) and held back by its Profitability (D-). Analysts rate it Buy with a $11.50 price target (+39.2% upside).
- Strongest
- MomentumA-
- Weakest
- ProfitabilityD-
All factor grades
- MomentumA-
- ForecastB
- GrowthC+
- ValuationC
- Financial StrengthC
- ProfitabilityD-
- Piotroski2/9
Contact
SOPH stock: frequently asked questions
What is SOPH's ST Score?
SOPHiA GENETICS S.A. (SOPH) has an ST Score of 41.5 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SOPH a buy, hold, or sell?
Analysts rate SOPH a Buy, with a price target of $11.50 (+39.2% vs the current price). Our ST Score grades it C (41.5/100). The ST Score is a data-driven signal, not a recommendation.
What are SOPH's factor grades?
Valuation C, Profitability D-, Financial Strength C, Momentum A-, Growth C+, Forecast B.
What is SOPH's valuation grade?
SOPHiA GENETICS S.A. (SOPH) earns a valuation grade of C, measured against Medical - Healthcare Information Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SOPH's growth grade?
SOPHiA GENETICS S.A. (SOPH) earns a growth grade of C+, measured against Medical - Healthcare Information Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SOPH's profitability grade?
SOPHiA GENETICS S.A. (SOPH) earns a profitability grade of D-, measured against Medical - Healthcare Information Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SOPH's financial strength grade?
SOPHiA GENETICS S.A. (SOPH) earns a financial strength grade of C, measured against Medical - Healthcare Information Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SOPH?
The average analyst price target for SOPHiA GENETICS S.A. (SOPH) is $11.50 from 8 analysts, which is +39.2% versus the recent price of $8.26.
What is SOPH's Piotroski score?
SOPHiA GENETICS S.A. (SOPH) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.